Lawrence Jasinski Net Worth

The estimated Net Worth of Lawrence J Jasinski is at least $2.09 Million dollars as of 5 March 2024. Mr. Jasinski owns over 5,110 units of Rewalk Robotics Ltd stock worth over $5,574 and over the last 18 years he sold RWLK stock worth over $1,079,067. In addition, he makes $1,007,290 as Chief Executive Officer and Director at Rewalk Robotics Ltd.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Jasinski RWLK stock SEC Form 4 insiders trading

Lawrence has made over 37 trades of the Rewalk Robotics Ltd stock since 2013, according to the Form 4 filled with the SEC. Most recently he sold 5,110 units of RWLK stock worth $344,925 on 5 March 2024.

The largest trade he's ever made was selling 22,920 units of Rewalk Robotics Ltd stock on 20 June 2023 worth over $13,523. On average, Lawrence trades about 2,332 units every 39 days since 2006. As of 5 March 2024 he still owns at least 5,309 units of Rewalk Robotics Ltd stock.

You can see the complete history of Mr. Jasinski stock trades at the bottom of the page.

Lawrence Jasinski biography

Lawrence J. Jasinski, also known as Larry, serves as Chief Executive Officer and Director at ReWalk Robotics Ltd since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski has served on the board of directors of Massachusetts Bay Lines since 2015 and of LeMaitre Vascular, Inc. since 2003. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.

What is the salary of Lawrence Jasinski?

As the Chief Executive Officer and Director of Rewalk Robotics Ltd, the total compensation of Lawrence Jasinski at Rewalk Robotics Ltd is $1,007,290. There are no executives at Rewalk Robotics Ltd getting paid more.

How old is Lawrence Jasinski?

Lawrence Jasinski is 62, he's been the Chief Executive Officer and Director of Rewalk Robotics Ltd since 2012. There are 5 older and 9 younger executives at Rewalk Robotics Ltd. The oldest executive at Rewalk Robotics Ltd is Ami Kraft, 78, who is the Exec. Advisor to the CEO.

What's Lawrence Jasinski's mailing address?

Lawrence's mailing address filed with the SEC is C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON, MA, 01803.

Insiders trading at Rewalk Robotics Ltd

Over the last 9 years, insiders at Rewalk Robotics Ltd have traded over $7,660,045 worth of Rewalk Robotics Ltd stock and bought 8,170,475 units worth $6,701,652 . The most active insiders traders include Global Fund Ii Lp Lind Glob..., Glenn P Muir, and Wayne Weisman. On average, Rewalk Robotics Ltd executives and independent directors trade stock every 26 days with the average trade being worth of $88,081. The most recent stock trade was executed by Global Fund Ii Lp Lind on 17 November 2023, trading 54,917 units of RWLK stock currently worth $40,089.

What does Rewalk Robotics Ltd do?

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the

Complete history of Mr. Jasinski stock trades at Lemaitre Vascular Inc and Rewalk Robotics Ltd

Rewalk Robotics Ltd executives and stock owners

Rewalk Robotics Ltd executives and other stock owners filed with the SEC include:

• Lawrence Jasinski,
  Chief Executive Officer, Director
• Lawrence J. Jasinski,
  CEO & Director
• Ori Gon,
  CFO & Principal Accounting Officer
• Wayne Weisman,
  Independent Director
• John Poduska,
  Independent Director
• Randel Richner,
  Director
• Yasushi Ichiki,
  Director
• Yohanan Engelhardt,
  Director
• Aryeh Dan,
  Director
• Jeff Dykan,
  Independent Chairman of the Board
• Jodi Gricci,
  Vice President - Global Marketing and Training
• Ofir Koren,
  Vice President - Research & Development
• Ori Gon,
  Chief Financial Officer
• Kathleen O'Donnell,
  VP of Marketing & New Bus. Devel.
• Ami Kraft,
  Exec. Advisor to the CEO
• Judy Kula,
  VP of Customer Service, HR & Bus. Affairs
• Andy Dolan,
  VP of Marketing & Reimbursement
• Miri Pariente,
  VP of Operations, Regulatory & Quality
• Peter Wehrly,
  Director
• Kevin Hershberger,
  Chief Financial Officer
• Vitalife Partners (Israel) ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Glenn P Muir,
  Director
• Deborah Di Sanzo Eldracher,
  Director
• Vitalife Partners (Israel) ...,
  
• John Vincent Hamilton,
  VP, Regulatory & Clinical
• Chunlin Han,
  Director
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners (Israel) ...,
  
• Ning Cong,
  
• Global Fund Ii Lp Lind Glob...,
  
• Joseph E Jr Turk,
  Director
• Jeannine Lynch,
  VP of Market Access & Strategy
• Hadar Levy,
  Director
• Almog Adar,
  VP of Finance
• Michael A Lawless,
  Chief Financial Officer
• Global Fund Ii Lp Lind,
  
• Charles Remsberg,
  Chief Sales Officer